Peter Fernandes
Voorzitter bij The Pulmonary Vascular Research Institute
Vermogen: 1 906 $ op 30-04-2024
Actieve functies van Peter Fernandes
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Voorzitter | - | - |
Loopbaan van Peter Fernandes
Eerdere bekende functies van Peter Fernandes
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BELLEROPHON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05-05-2023 | 15-11-2023 |
Algemeen Directeur | 11-11-2021 | 15-11-2023 | |
Financieel Directeur/CFO | 05-05-2023 | 15-11-2023 | |
Algemeen Adviseur | 20-05-2015 | 15-11-2023 | |
IKARIA, INC. | Algemeen Adviseur | 01-10-2012 | 01-05-2015 |
OPTINOSE, INC. | Algemeen Adviseur | 01-10-2010 | 01-09-2012 |
Novartis Pharmaceuticals AG | Corporate Officer/Principal | 01-11-2007 | 01-10-2010 |
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Algemeen Adviseur | 01-02-2005 | 01-10-2007 |
Opleiding van Peter Fernandes
The Grant Government Medical College | Graduate Degree |
Principal K. M. Kundnani College of Pharmacy | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
India | 3 |
Verenigd Koninkrijk | 2 |
Operationeel
General Counsel | 4 |
Comptroller/Controller/Auditor | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
OPTINOSE, INC. | Health Technology |
BELLEROPHON THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Ikaria, Inc.
Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Health Technology |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Commercial Services |
Novartis Pharmaceuticals AG |
- Beurs
- Insiders
- Peter Fernandes
- Ervaring